# Maxcyte, Inc.: Form 8-K, filed Jun 12, 2024

- Company: [Maxcyte, Inc.](/companies/mxct.md) (CIK 1287098)
- Form: 8-K
- Filed: 2024-06-12
- Accepted by EDGAR: Jun 12, 2024, 16:45 ET
- Period: 2024-06-11
- Accession: 0001558370-24-009097
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1287098/000155837024009097/mxct-20240611x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1287098/000155837024009097/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1287098/000155837024009097/mxct-20240611x8k.htm

Filed Jun 12, 2024.
Source: SEC EDGAR, the filing index for accession 0001558370-24-009097. Last ingested by Listed: Nov 2, 2026, 10:20 ET. No prices; not investment advice.